American National Bank & Trust (Virginia)’s Teva Pharmaceuticals TEVA Stock Holding History

American National Bank & Trust (Virginia)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$285K	Hold	4,345	–	–	0.14%	108
2015 Q3	$245K	Hold	4,345	–	–	0.12%	112
2015 Q2	$257K	Sell	4,345 -979	-18%	-$60.4K	0.12%	117
2015 Q1	$332K	Sell	5,324 -3,021	-36%	-$176K	0.16%	114
2014 Q4	$480K	Sell	8,345 -3,423	-29%	-$191K	0.23%	101
2014 Q3	$633K	Sell	11,768 -7,834	-40%	-$415K	0.31%	87
2014 Q2	$1.03M	Sell	19,602 -3,948	-17%	-$202K	0.52%	57
2014 Q1	$1.24M	Buy	23,550 +1,750	+8%	+$80.9K	0.64%	50
2013 Q4	$874K	Sell	21,800 -100	-0.5%	-$3.94K	0.44%	58
2013 Q3	$827K	Buy	21,900 +2,650	+14%	+$103K	0.45%	60
2013 Q2	$755K	Buy	+19,250	New	+$750K	0.42%	63

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

American National Bank & Trust (Virginia)'s TEVA Position: Q4 2015 in Review

American National Bank & Trust (Virginia) held its Teva Pharmaceuticals (TEVA) position steady in Q4 2015 at 4,345 shares worth $285K. The position accounts for 0.14% of the portfolio, ranked #108.

American National Bank & Trust (Virginia) first reported a position in TEVA in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.24M in Q1 2014. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

American National Bank & Trust (Virginia) held 4,345 shares of Teva Pharmaceuticals worth $285K as of Q4 2015.
American National Bank & Trust (Virginia) left its Teva Pharmaceuticals share count unchanged in Q4 2015.
Teva Pharmaceuticals made up 0.14% of American National Bank & Trust (Virginia)'s portfolio in Q4 2015, its #108 holding.
American National Bank & Trust (Virginia) first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 11 quarters since.
American National Bank & Trust (Virginia)'s Teva Pharmaceuticals position peaked at $1.24M in Q1 2014.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q4 2015, filed 9 Feb 2016.